Childhood Schizophrenia

01/01/2003 - "Olanzapine appears useful in the treatment of childhood-onset schizophrenia, although there may be a delayed onset of benefit for anxiety and negative symptoms. "
04/01/1998 - "This pilot study examined the efficacy of olanzapine for treatment-refractory childhood-onset schizophrenia in eight patients who had received 8-week open-label trials. "
01/01/2003 - "The aim of the present study was to examine the effectiveness of the atypical antipsychotic olanzapine in the treatment of childhood-onset schizophrenia. "
01/01/2003 - "Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study."
01/01/2003 - "To determine the response of children with childhood-onset schizophrenia to a 1-year prospective, open-label trial of olanzapine. "

12/01/1998 - "Some of the atypical neuroleptics may become the first-line treatment for childhood schizophrenia and pervasive developmental disorders."
01/01/2004 - "Further double-blind, placebo-controlled trials and long-term safety assessments are needed before definitive conclusions can be reached about the place of atypical antipsychotics in the therapeutic armamentarium of childhood-onset schizophrenia."
08/01/2008 - "This review encompasses and elaborates on the efficacy, safety and tolerability data available at present for both typical and atypical antipsychotics for treatment of childhood schizophrenia. "
02/01/2008 - "Pediatric bipolar I disorder (BP-I) and childhood schizophrenia (SZ) share certain symptoms (e.g., psychosis, aggression/irritability [A/I]), and the psychotic and A/I features are treated with neuroleptics in both disorders. "
04/01/1996 - "Caudate enlargement in patients with childhood-onset schizophrenia who are taking typical neuroleptics appears to be secondary to medication exposure. "

09/01/1977 - "Coexisting childhood schizophrenia and myasthenia gravis treated successfully with neostigmine bromide."

02/01/2008 - "Available studies in the literature using clozapine in the pediatric population are summarized and the NIMH experience in treating refractory childhood-onset schizophrenia cases with clozapine is discussed. "
06/01/1997 - "An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia."
06/01/1994 - "To review the response of 11 adolescents with childhood-onset schizophrenia to a 6-week open clozapine trial. "
06/01/1994 - "An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia."
10/01/2007 - "Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome."

11/01/2004 - "Because the diagnostic of childhood-onset schizophrenia was suspected, a neuroleptic treatment, haloperidol 3 mg/day, was tried. "
01/01/2007 - "A few results from one study favoured the atypical antipsychotic clozapine over haloperidol in treating treatment resistant childhood-onset schizophrenia (n=21, WMD CGAS 17.00 CI 7.74 to 26.26; n=21, WMD Bunney-Hamburg Psychosis Rating Scale -3.60 CI -6.64 to -0.56). "
09/01/1994 - "Plasma clozapine and haloperidol concentrations were studied in adolescents being treated for childhood-onset schizophrenia. "
09/01/1994 - "Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response."
01/01/1999 - "The National Institute of Mental Health patients--13 females, 22 males (mean age, 14.1+/-2.3 years; range, 9.1-19 years) with childhood onset schizophrenia (n = 32), or Psychotic Disorder not otherwise specified (NOS) (n = 3) with onset of psychosis before age 13--were recruited for open or double-blind trials of haloperidol, clozapine, or olanzapine. "

01/01/1973 - "Studies on erythrocyte magnesium and potassium levels in childhood schizophrenia and growth."
04/01/1969 - "Studies on erythrocyte magnesium and potassium levels in childhood schizophrenia and growth."
09/01/1984 - "[Effect of increased levels of trace elements in the blood on erythrocyte membrane permeability to sodium and potassium ions in childhood schizophrenia]."

10/01/1971 - "Serum magnesium differences: further evidence for discontinuity between adult and childhood schizophrenia."
01/01/1973 - "Studies on erythrocyte magnesium and potassium levels in childhood schizophrenia and growth."
04/01/1969 - "Studies on erythrocyte magnesium and potassium levels in childhood schizophrenia and growth."

01/01/1971 - "Biological studies in childhood schizophrenia: serotonin uptake by platelets."
01/01/1977 - "Previous work indicated a platelet abnormality in the in vitro accumulation of serotonin in childhood schizophrenia, especially infantile autism. "
01/01/1977 - "Uptake of 5-hydroxytryptamine by isolated platelets in childhood schizophrenia and autism."

04/01/2004 - "This study used proton magnetic resonance spectroscopic imaging ((1)H MRSI) to identify potential metabolic abnormalities in these regions in childhood-onset schizophrenia. "
12/01/2011 - "Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia."

09/01/2005 - "In this study, the authors examined six weight gain-related hormones in patients with childhood-onset schizophrenia (COS) after 6 weeks of clozapine treatment. "

04/01/1974 - "Organic factors and psychophysiology in childhood schizophrenia."

07/01/1971 - "Relative effectiveness of operant conditioning and play therapy in childhood schizophrenia."

11/01/1973 - "Language therapy in childhood schizophrenia: a case study of a monitoring and feedback approach."